Pregnancy-Related Mortality Due to Cardiovascular Conditions: Maternal Mortality Review Committees in 32 U.S. States,

Joan Briller1, Susanna L Trost2, Ashley Busacker2

  • 1Division of Cardiology, Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.

JACC. Advances
|November 25, 2024
PubMed

Insights

Most pregnancy-related deaths from cardiovascular conditions (CVs), including cardiomyopathy (CM), are preventable. Maternal Mortality Review Committees identified key factors and recommend improved awareness and care coordination to reduce these tragic deaths.

Area of Science:

  • Cardiovascular Health
  • Maternal Health
  • Public Health Surveillance

Background:

  • Cardiomyopathy (CM) and other cardiovascular conditions (OCVs) are leading causes of pregnancy-related mortality in the U.S.
  • Understanding the characteristics and preventability of these deaths is crucial for improving maternal outcomes.

Purpose of the Study:

  • To analyze demographic and clinical factors of pregnancy-related deaths due to CM, OCVs, and combined cardiovascular conditions (CVs).
  • To identify contributing factors and review Maternal Mortality Review Committee (MMRC) recommendations for prevention.

Main Methods:

  • Analysis of pregnancy-related death data from MMRCs in 32 states (2017-2019).
  • Focus on deaths with underlying causes of CVs, including CM and OCVs.
  • Description of demographic distributions, frequent contributing factors, and MMRC prevention recommendations.

Main Results:

  • 210 pregnancy-related deaths attributed to CVs (40% CM, 60% OCVs).
  • Over 75% of these deaths were deemed preventable by MMRCs.
  • Key contributing factors and multilevel prevention recommendations were identified.

Conclusions:

  • The majority of pregnancy-related deaths from CM and OCVs are preventable.
  • MMRC recommendations highlight opportunities for prevention through increased awareness of warning signs, enhanced care coordination, and improved access to integrated services.
Abstract

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
5
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
436
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59